Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Digital Revolution to Bust COVID Backlogs and Deliver More Tailored Care for Patients
People across the country will benefit from faster, more personalised healthcare, following a digital revolution […]
Patients to Have Earlier Access to Cutting-edge Treatments on NHS
NHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks […]
One Million Checks Delivered By NHS ‘One Stop Shops’
NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]
New Clinical Trials Deal Struck to Better Protect World From Future Pandemics
Millions of people across the world will be better protected from future pandemics thanks to […]
Hundreds of Patients to Get Life-extending Lung Cancer Drug on the NHS
Hundreds of people with a form of the most common form of lung cancer could […]
New State-Of-The-Art NHS Hospital To Help Tackle Covid Backlog
A new ‘planned care’ hospital dedicated to non-emergency treatment is due to open in Berkshire […]
NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer
A targeted new drug for a rare and aggressive form of lung cancer will be […]
New UK-wide Ambitions to Accelerate Genomic Research and Drive Innovation in Healthcare
Patients across the UK are set to benefit from faster cancer diagnosis and innovative new […]
Life-extending Injection for Blood Cancer Available on the NHS
A life-extending injection for a fatal form of blood cancer will be available to around […]
Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS
A revolutionary targeted drug for lung cancer will be made available to anyone who is […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more